StonvexLoading…
StonvexStonvexStonvexCore line items from ABG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $17.19B | $14.80B | $15.43B | $9.84B |
Operating Income | $835.60M | $953.50M | $1.27B | $791.80M |
Net Income | $430.30M | $602.50M | $997.30M | $532.40M |
EPS (Diluted) | $21.50 | $28.74 | $44.61 | $26.49 |
Total Assets | $10.34B | $10.16B | $8.02B | $8.00B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $69.40M | $45.70M | $235.30M | $178.90M |
Free Cash Flow OCF − CapEx | Not available | $170.70M | $601.40M | $1.09B |
Shares Outstanding | 20.00M | 21.00M | 22.40M | 20.10M |